bismuth has been researched along with Benign Neoplasms in 116 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (21.55) | 18.7374 |
| 1990's | 5 (4.31) | 18.2507 |
| 2000's | 12 (10.34) | 29.6817 |
| 2010's | 33 (28.45) | 24.3611 |
| 2020's | 41 (35.34) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, R; Dong, L; Du, Y; Feng, J; Li, K; Wang, D; Wen, D; Zhang, H | 1 |
| Bao, S; Bao, W; Ge, C; Gu, M; Huang, H; Kutscher, HL; Liu, L; Prasad, PN; Qiu, M; Wang, D; Wang, Q; Wu, Z; Xie, N; Xie, Z; Yin, T; Zhang, B; Zhang, H | 1 |
| Du, J; Li, Y; Miao, Y; Ouyang, R; Song, K; Wang, X; Zhang, D; Zheng, L | 1 |
| Cai, R; Chen, C; Li, X; Liu, T; Ovais, M; Ren, J; Wang, Z; Wen, S | 1 |
| Cang, F; Fu, Y; Jiang, Y; Jin, Y; Li, Y; Qu, X; Wu, S; Zhang, Q; Zhang, X; Zhao, Q; Zhao, T; Zhou, Y | 1 |
| Chen, S; Duan, M; Fan, L; Guo, R; He, Y; Liu, J; Sun, X; Yang, C; Zhu, X | 1 |
| Csige, K; Dénes, NS; Fenyvesi, F; Hajdu, I; Kálmán-Szabó, I; Képes, Z; Kertész, I; Méhes, G; Opposits, G; Szabó, JP; Szikra, D; Trencsényi, G | 1 |
| Chen, G; Li, Y; Liu, B; Miao, Y | 1 |
| Li, J; Liu, B; Liu, Z; Yao, S; Zhang, X | 1 |
| Chen, G; He, Z; Li, Y; Miao, Y; Ping, J; Shen, J; Song, K; Zhang, D; Zheng, L | 1 |
| Cao, Q; Cao, Z; Li, B; Liu, J; Xiao, M; Yang, C; Yao, Y | 1 |
| Ding, Y; Hu, Q; Li, L; Wan, X; Wang, S; Yao, S; Zhao, Y | 1 |
| Chen, D; Huo, M; Liu, C; Liu, J; Miao, S; Shen, Y; Wang, L; Wang, Q; Wen, J | 1 |
| Choghazardi, Y; Kazemzadeh, A; Naseri, P; Shahbazi-Gahrouei, D; Shahbazi-Gahrouei, S | 1 |
| Cao, Y; Chen, H; He, Y; Li, W; Wang, D; Wang, Z; Xu, L; Yao, H; Zhang, L; Zhou, D | 1 |
| Cai, S; Chen, G; Chen, M; Du, J; He, Z; Li, Y; Miao, Y; Yang, Z; Zhang, D; Zhang, Y; Zheng, K; Zheng, L | 1 |
| Hu, Q; Li, L; Wang, S; Zhang, Z; Zhao, Y; Zhong, S | 1 |
| Bruchertseifer, F; Morgenstern, A | 1 |
| Ferrier, MG; Radchenko, V | 1 |
| Deng, G; Hu, J; Ji, T; Liu, F; Liu, X; Lu, J; Ren, L; Yu, J; Yuan, H | 1 |
| Dong, L; Feng, Y; Shao, B; Tian, R; Wang, Z; You, H; Yuan, S; Zhang, L; Zhao, S | 1 |
| Chen, Y; Chu, PK; Jiang, Z; Liu, B; Liu, M; Luo, G; Shao, J; Xie, H; You, B; Yu, XF | 1 |
| Cheng, R; Dong, X; Gu, Z; Liu, H; Wang, Q; Yan, L; Zhang, C; Zhao, Y; Zhou, R; Zhu, S | 1 |
| Faghfouri, L; Ferreira, MPA; Figueiredo, P; Hirvonen, J; Maleki, H; Santos, HA; Sefat, F; Shahbazi, MA | 1 |
| Chang, Y; Cheng, Y; Feng, Y; Gao, X; Kong, X; Wu, X; Xu, K; Zhang, H; Zheng, R | 1 |
| Badrigilan, S; Choupani, J; Hoseini-Ghahfarokhi, M; Khanbabaei, H; Tayebi, L; Webster, TJ | 1 |
| Bu, W; Cheng, H; Gong, T; Liu, Y; Meng, X; Wang, B; Wang, H; Yang, W; Yao, Y; Yi, Y; Zhang, B | 1 |
| Chen, Y; Huang, M; Jia, C; Luo, K; Wang, S; Zhang, J; Zhang, Z; Zhao, J | 1 |
| Chen, Q; Dai, R; Jia, Z; Peng, X; Yang, C; Zhang, R; Zheng, Z | 1 |
| Feng, L; Gai, S; He, F; Yang, P; Zhao, Y | 1 |
| Li, N; Li, W; Liu, P; Lu, Q; Ren, C; Song, Y; Tan, F; Wang, Y; Xu, M; Yang, L; Zhu, Y | 1 |
| Copping, R; DeGraffenreid, AJ; Graves, S; Johnson, FL; Larsen, RH; Lee, D; Li, M; McAlister, D; Mirzadeh, S; Olewine, KR; Sagastume, EA; Schultz, MK; Zimmerman, BE | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Cao, J; Chen, C; Gu, Z; Li, J; Li, Y; Liu, R; Liu, X; Liu, Z; Wu, Y; Xiang, H; Yan, L; Yin, W; Zhao, F; Zhao, Y; Zhou, R; Zu, Y | 1 |
| Banstola, A; Choi, HG; Gautam, M; Jeong, JH; Kim, JO; Ku, SK; Pham, LM; Poudel, K; Soe, ZC; Tran, TH; Yong, CS | 1 |
| Chen, Z; Geng, P; Jiang, Q; Lu, C; Macharia, DK; Ren, X; Sharjeel, A; Yan, H; Yang, S; Yu, N | 1 |
| Luo, X; Ma, S; Ran, G; Wang, L; Xie, J; Yan, J; Zhou, Z | 1 |
| He, X; Jiang, W; Lu, LG; Ma, YC; Tang, XF; Xin, YJ; Xu, YC; Zhan, MX; Zhao, W | 1 |
| Brown, V; Fiszbein, DJ; MacMillan, SN; Radchenko, V; Ramogida, CF; Thiele, NA; Wharton, L; Wilson, JJ; Woods, JJ | 1 |
| He, J; Hu, J; Li, P; Wang, D; Yang, X; Yao, Y | 1 |
| Belousov, AV; Dement'eva, OV; Isagulieva, AK; Kartseva, ME; Kolyvanova, MA; Krivoshapkin, PV; Krusanov, GA; Morozov, KV; Morozov, VN; Rudoy, VM; Salpagarov, MH | 1 |
| Du, J; Li, B; Li, Y; Liu, J; Miao, Y; Ouyang, R; Song, K; Sun, Y; Wang, X; Zhang, J | 1 |
| Chen, W; Jiang, C; Liu, J; Lu, L; Sun, Z; Yu, B | 1 |
| Ding, M; Guo, N; Li, Y; Liu, J; Miao, Y; Ouyang, R; Wang, H; Xie, X; Yang, J; Yang, X | 1 |
| Allen, BJ | 3 |
| Korolczuk, M; Stępniowska, A; Sztanke, K; Sztanke, M; Tuzimski, T | 1 |
| Chen, X; Li, A; Li, W; Yang, K; Yu, X; Zhao, C | 1 |
| Besenbacher, F; Chen, C; Fan, X; Hu, Y; Li, Z; Liu, J; Sun, Y; Yu, M | 1 |
| Chen, C; Du, J; Ge, C; Gu, Z; Liu, J; Wu, R; Yan, L; Yi, X; Yong, Y; Zhang, X; Zhao, Y | 1 |
| Du, F; Fang, Z; Gong, A; Jiang, R; Lou, J; Niu, Y; Wu, C; Zhang, M; Zhao, X; Zou, S | 1 |
| Chang, Y; Cheng, Y; Feng, Y; Jian, H; Tang, Z; Zhang, H | 1 |
| He, J; Hu, X; Hyeon, T; Kim, D; Li, F; Li, R; Ling, D; Liu, J; Sun, J; Sun, X; Wang, N; Wang, S; Wu, J; Zhou, F | 1 |
| Apostolidis, C; Bruchertseifer, F; Kratochwil, C; Krolicki, L; Morgenstern, A; Sathekge, M | 1 |
| Cheng, Y; Zhang, H | 1 |
| Bednarz, B; Lee, D; Li, M; Schultz, MK | 1 |
| Dong, X; Gu, Z; Liu, X; Song, L; Yin, W; Zhang, C; Zhang, X; Zhu, S | 1 |
| Knapp, FFR; Radchenko, V; Schaffer, P | 1 |
| Hou, M; Kang, Y; Qian, D; Sun, L; Xu, Z; Xue, P; Yang, Q; Zhang, L | 1 |
| Beladi-Mousavi, SM; Fisher, AC; Heger, Z; Khezri, B; Krejčová, L; Pumera, M; Sofer, Z | 1 |
| An, S; Jia, X; Jiang, X; Liu, Y; Wang, C; Wang, W; Zhang, M; Zhen, W | 1 |
| Chen, Z; Li, M; Li, Z; Peng, C; Song, C; Wang, H; Wang, S; Wang, Z; Xu, H; Yu, W | 1 |
| Bruchertseifer, F; Essler, M; Gaertner, FC; Morgenstern, A; Seidl, C; Senekowitsch-Schmidtke, R; Wulbrand, C | 1 |
| An, X; Cai, X; Chen, H; Chen, Y; Gao, W; Li, X; Shi, J; Wang, S; Yao, H; Zheng, Y | 1 |
| Brown, EM; Shi, Z; Wu, A; Xu, Y; Zhang, L | 1 |
| Demicheli, C; Dittz, D; Frézard, F; Ishfaq, M; Islam, A; Marzano, IM; Paz Lopes, MT; Perreira-Maia, EC; Rodrigues, BL | 1 |
| Cheng, L; Liang, C; Liu, Z; Song, G; Yang, K; Yi, X; Zhao, Q | 1 |
| Cao, M; Chen, C; Gu, Z; Guo, M; Liu, J; Liu, Y; Tang, J; Wang, D; Wang, L; Wang, P; Zhang, X; Zhou, H | 1 |
| Mohana Roopan, S; Samuel, EJ; Titus, D | 1 |
| Beraldo, H; Da Silva, JG; Ferreira, IP; Marques, LB; Piló, EDL; Prazeres, PHDM; Ramos, JP; Recio-Despaigne, AA; Rocha, W; Souza-Fagundes, EM; Takahashi, JA | 1 |
| Hirata, K; Katoh, C; Katoh, N; Kojima, S; Kubo, N; Morimoto, Y; Shiga, T; Shirato, H; Takeuchi, W; Tamaki, N; Umegaki, K; Usui, R | 1 |
| Brockman, J; Hawthorne, MF; McKibben, C; Nigg, DW | 1 |
| SHIRCORE, JO | 1 |
| BONNAYME, R; DUVERNE, J | 1 |
| Boitrel, B; Brothers, PJ; Lemon, CM | 1 |
| Baidoo, KE; Brechbiel, MW; Chong, HS; Dadwal, M; Dai, A; Kang, CS; Song, HA; Sun, X | 1 |
| Apostolidis, C; Bruchertseifer, F; Morgenstern, A | 2 |
| Skrdla, PJ | 1 |
| Apostolidis, C; Becker, KF; Beyer, GJ; Charlton, DE; Comor, JJ; Huber, R; Miederer, M; Nikula, T; Schuhmacher, C; Seidl, C; Senekowitsch-Schmidtke, R; Vranjes-Duric, S | 1 |
| VAN DER WERFF, JT | 1 |
| MUNDINGER, F | 3 |
| PASSALACQUA, F | 2 |
| HAANEN, CA; VAN DER WERFF, JT | 1 |
| IVY, AC; JANECEK, HM; KAHN, H | 1 |
| van der WERFF, J | 1 |
| MANGANIELLO, A; NINFO, G | 1 |
| GERHARD, H; MUNDINGER, F | 1 |
| ORTIZBERROCAL, J | 1 |
| LINDGREN, E; WESTBERG, G | 1 |
| FEINDEL, W; MCRAE, DL; YAMAMOTO, YL; ZANELLI, J | 1 |
| ARAKI, M; FUJITA, M | 1 |
| Allen, BJ; Graham, P; Kearsley, J; Li, Y; Qu, CF; Raja, C; Rizvi, S; Song, E; Thompson, J; Tsui, W; Zhang, D | 1 |
| Pozzi, OR; Zalutsky, MR | 1 |
| Anderson, T; Atcher, R; Nayak, T; Norenberg, J | 1 |
| Bethge, WA; Sandmaier, BM; Wilbur, DS | 1 |
| Waldmann, TA | 1 |
| Vaidyanathan, G; Zalutsky, MR | 1 |
| Adamek, GD; Saenger, EL | 1 |
| Brechbiel, MW; Chappell, LL; Davern, SM; Foote, LJ; Glowienka, KA; Hurst, GB; Kelso, JR; Kennel, SJ; Lankford, TK; Mirzadeh, S; Safavy, A | 1 |
| Brechbiel, MW | 1 |
| Imam, SK | 1 |
| Tiekink, ER | 1 |
| Luyckx, A; Van Cauwenberge, H | 1 |
| Silberstein, EB | 1 |
| Olivares Muñoz, P; Perez Modrego, S; Perez Torrubia, A | 1 |
| Vanchieri, C | 1 |
| Kawamura, E; Morikawa, T | 1 |
| Ludvigsson, J; Samuelsson, L; Stjernfeldt, M | 1 |
| Gottschalk, A; Hoffer, PB | 1 |
| Lundell, G | 1 |
| Kraus, N; Thomas, H | 1 |
27 review(s) available for bismuth and Benign Neoplasms
| Article | Year |
|---|---|
Tailoring bismuth-based nanoparticles for enhanced radiosensitivity in cancer therapy.
Topics: Bismuth; Humans; Nanoparticles; Neoplasms; Phototherapy; Radiation Tolerance; Theranostic Nanomedicine | 2022 |
Recent developments in bismuth oxyhalide-based functional nanomaterials for biomedical applications.
Topics: Anti-Bacterial Agents; Bismuth; Contrast Media; Humans; Nanomedicine; Nanostructures; Neoplasms | 2022 |
A review of bismuth-based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy.
Topics: Bismuth; Humans; Nanoparticles; Neoplasms; Radiation-Sensitizing Agents | 2023 |
Development of Targeted Alpha Therapy from Bench to Bedside.
Topics: Actinium; Alpha Particles; Bismuth; History, 20th Century; History, 21st Century; Humans; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy | 2019 |
An Appendix of Radionuclides Used in Targeted Alpha Therapy.
Topics: Actinium; Alpha Particles; Astatine; Bismuth; Humans; Neoplasms; Radioisotopes; Radiotherapy; Radium; Thorium | 2019 |
The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties.
Topics: Biosensing Techniques; Bismuth; Bone Regeneration; Contrast Media; Humans; Metal Nanoparticles; Multimodal Imaging; Neoplasms; Phototherapy; Theranostic Nanomedicine | 2020 |
Bismuth-Based Nanomaterials: Recent Advances in Tumor Targeting and Synergistic Cancer Therapy Techniques.
Topics: Bismuth; Combined Modality Therapy; Humans; Nanostructures; Neoplasms; Phototherapy | 2020 |
Topics: Bismuth; Humans; Lead Radioisotopes; Neoplasms; Precision Medicine; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
How Do Bismuth-Based Nanomaterials Function as Promising Theranostic Agents for the Tumor Diagnosis and Therapy?
Topics: Bismuth; Cell Line, Tumor; Humans; Nanoparticles; Nanostructures; Neoplasms; Photoacoustic Techniques; Phototherapy; Precision Medicine; Theranostic Nanomedicine; Tomography, X-Ray Computed; Tumor Microenvironment | 2022 |
An Overview of Targeted Alpha Therapy with
Topics: Actinium; Alpha Particles; Bismuth; Clinical Trials as Topic; Humans; Neoplasms; Radiochemistry; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals | 2018 |
Novel Bismuth-Based Nanomaterials Used for Cancer Diagnosis and Therapy.
Topics: Animals; Bismuth; Humans; Nanostructures; Neoplasms; Photoacoustic Techniques; Phototherapy; Reactive Oxygen Species; Theranostic Nanomedicine; Tomography, X-Ray Computed | 2018 |
Current scenario of biomedical aspect of metal-based nanoparticles on gel dosimetry.
Topics: Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Gadolinium; Gels; Gold; Hafnium; Humans; Iodine; Iron; Metal Nanoparticles; Nanotechnology; Neoplasms; Oxides; Platinum; Radiometry; Radiotherapy Dosage; Silver | 2016 |
Targeted alpha therapy with 213Bi.
Topics: Alpha Particles; Animals; Bismuth; Humans; Isotope Labeling; Neoplasms; Radioisotopes; Radiopharmaceuticals | 2011 |
Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
Topics: Actinium; Aged; Aged, 80 and over; Alpha Particles; Animals; Bismuth; Clinical Trials as Topic; Humans; Mice; Mice, Transgenic; Middle Aged; Neoplasms; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals | 2012 |
[RADIOACTIVE ISOTOPES IN THE NEUROLOGICAL DIAGNOSIS].
Topics: Arsenic; Bismuth; Boron; Brain Neoplasms; Copper; Fluoresceins; Fluorine; Humans; Iodine Isotopes; Mercury; Neoplasms; Potassium Isotopes; Radioisotopes; Radionuclide Imaging; Rubidium; Serum Albumin; Serum Albumin, Radio-Iodinated | 1963 |
Radioimmunotherapy with alpha-particle emitting radionuclides.
Topics: Actinium; Alpha Particles; Antibodies, Monoclonal; Astatine; Bismuth; Humans; Isotopes; Neoplasms; Practice Patterns, Physicians'; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Treatment Outcome | 2004 |
Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.
Topics: Animals; Bismuth; Bone Marrow Transplantation; Dogs; Humans; Neoplasms; Radioimmunotherapy; Radioisotopes; Time Factors; Tissue Distribution; Transplantation Conditioning; Transplantation, Homologous | 2006 |
Genetically engineered monoclonal antibodies armed with radionuclides.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Bismuth; CD4 Antigens; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Neoplastic; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Neoplasm Proteins; Neoplasms; Protein Engineering; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Yttrium Radioisotopes | 1993 |
Targeted therapy using alpha emitters.
Topics: Alpha Particles; Antibodies, Monoclonal; Astatine; Bismuth; Cyclotrons; Humans; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy | 1996 |
Marie Curie and nuclear medicine: closure of a circle.
Topics: Bismuth; France; History, 20th Century; Humans; Neoplasms; Nobel Prize; Nuclear Medicine; Radioisotopes; Radium | 1999 |
Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
Topics: Alpha Particles; Animals; Astatine; Bismuth; Humans; Immunoconjugates; Mice; Neoplasm Metastasis; Neoplasms; Radioisotopes; Terbium; Tumor Cells, Cultured | 1999 |
Chelated metal ions for therapeutic and diagnostic applications.
Topics: Animals; Antibodies, Monoclonal; Bismuth; Chelating Agents; Humans; Isotope Labeling; Isotopes; Metals; Neoplasms; Pentetic Acid | 2001 |
Advancements in cancer therapy with alpha-emitters: a review.
Topics: Actinium; Alpha Particles; Antibodies, Monoclonal; Astatine; Beta Particles; Bismuth; Cell Death; Energy Transfer; Fermium; Humans; Immunoconjugates; Neoplasms; Radioisotopes; Radium; Relative Biological Effectiveness; Terbium | 2001 |
Antimony and bismuth compounds in oncology.
Topics: Animals; Antimony; Antineoplastic Agents; Bismuth; Cell Division; Humans; Neoplasms; Organometallic Compounds; Structure-Activity Relationship | 2002 |
Cancer diagnosis. The role of tumor-imaging radiopharmaceuticals.
Topics: Antibodies, Neoplasm; Bismuth; Bleomycin; Carcinoembryonic Antigen; Cesium Radioisotopes; Chelating Agents; Chloroquine; Cobalt Radioisotopes; Copper; Gallium Radioisotopes; Glycerophosphates; Humans; Indium; Mercury Radioisotopes; Metals, Rare Earth; Naphthoquinones; Neoplasms; Porphyrins; Proteins; Pyrimidines; Radioisotopes; Radionuclide Imaging; Selenium; Technetium; Tetracycline | 1976 |
Tumor scanning agents.
Topics: Antibodies, Neoplasm; Aspartic Acid; Bismuth; Bleomycin; Carbon Radioisotopes; Carcinoembryonic Antigen; Carcinoma, Hepatocellular; Cobalt Radioisotopes; Gallium; Hodgkin Disease; Humans; Indium; Iodine Radioisotopes; Liver Neoplasms; Lymphoma; Mediastinal Neoplasms; Melanoma; Methionine; Neoplasms; Radionuclide Imaging; Selenium; Serum Albumin; Tonsillar Neoplasms | 1974 |
1 trial(s) available for bismuth and Benign Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
89 other study(ies) available for bismuth and Benign Neoplasms
| Article | Year |
|---|---|
Selenium Vacancy Engineering Using Bi
Topics: Animals; Antineoplastic Agents; Bismuth; Cattle; Cell Line, Tumor; Contrast Media; Density Functional Theory; Female; Folic Acid; Infrared Rays; Mice, Inbred BALB C; Models, Chemical; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Quantum Dots; Selenium Compounds; Serum Albumin, Bovine | 2021 |
A Regioselectively Oxidized 2D Bi/BiOx Lateral Nano-Heterostructure for Hypoxic Photodynamic Therapy.
Topics: Bismuth; Humans; Hypoxia; Neoplasms; Oxygen; Photochemotherapy; Photosensitizing Agents; Tumor Microenvironment | 2021 |
Biodegradable Bismuth-Based Nano-Heterojunction for Enhanced Sonodynamic Oncotherapy through Charge Separation Engineering.
Topics: Bismuth; Cell Line, Tumor; Humans; Neoplasms; Reactive Oxygen Species; Tumor Hypoxia; Ultrasonic Therapy | 2022 |
Yolk-shell shaped Au-Bi
Topics: Berberine; Bismuth; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Liberation; Gold; Humans; Metal Nanoparticles; Nanoparticles; Neoplasms; Pharmaceutical Preparations; Phototherapy; Sulfides | 2022 |
Phase-Transitional Bismuth-Based Metals enable Rapid Embolotherapy, Hyperthermia, and Biomedical Imaging.
Topics: Bismuth; Embolization, Therapeutic; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Neoplasms | 2022 |
In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice.
Topics: Animals; beta-Cyclodextrins; Bismuth; Cell Line, Tumor; Dinoprostone; Gallium Radioisotopes; Mice; Mice, SCID; Neoplasms; Positron-Emission Tomography; Radioisotopes; Receptors, Prostaglandin; Tissue Distribution | 2022 |
Multifunctional Bi NSs@BSA Nanoplatform Guided by CT Imaging for Effective Photothermal Therapy.
Topics: Bismuth; Cell Line, Tumor; Humans; Nanomedicine; Nanoparticles; Nanostructures; Neoplasms; Phototherapy; Photothermal Therapy; Serum Albumin, Bovine; Tomography, X-Ray Computed | 2022 |
Protoporphyrin-sensitized degradable bismuth nanoformulations for enhanced sonodynamic oncotherapy.
Topics: Bismuth; Cell Line, Tumor; Glutathione; Humans; Neoplasms; Protoporphyrins; Reactive Oxygen Species; Tumor Microenvironment; Ultrasonic Therapy | 2023 |
Learning from human metabolism for nanomedicine: a convertible bismuth-agent for tumour-selective theranostics.
Topics: Bismuth; Humans; Nanomedicine; Neoplasms; Precision Medicine; Theranostic Nanomedicine | 2023 |
Enhanced Sonodynamic Cancer Therapy through Iron-Doping and Oxygen-Vacancy Engineering of Piezoelectric Bismuth Tungstate Nanosheets.
Topics: Animals; Bismuth; Cell Line, Tumor; Iron; Mice; Neoplasms; Oxygen; Reactive Oxygen Species; Tumor Microenvironment; Ultrasonic Therapy | 2023 |
Dextran 40 hybrid biomimetic bismuth-nanoflower designed for NIR II-triggered hypoxic tumor thermoradiotherapy via macrophage escape.
Topics: Biomimetics; Bismuth; Cell Line, Tumor; Dextrans; Humans; Macrophages; Nanoparticles; Neoplasms | 2023 |
3-Bromopyruvate-loaded bismuth sulfide nanospheres improve cancer treatment by synergizing radiotherapy with modulation of tumor metabolism.
Topics: Bismuth; Cell Line, Tumor; Nanospheres; Neoplasms; Sulfides | 2023 |
Topological Regulating Bismuth Nano-Semiconductor for Immunogenic Cell Death-Mediated Sonocatalytic Hyperthermia Therapy.
Topics: Bismuth; Cell Line, Tumor; Humans; Hyperthermia, Induced; Immunogenic Cell Death; Immunotherapy; Neoplasms; Reactive Oxygen Species; Sulfur | 2023 |
Bismuth nanoclusters on nitrogen-doped porous carbon nanoenzyme for cancer therapy.
Topics: Bismuth; Carbon; Cell Line, Tumor; Glutathione; Humans; Hyaluronic Acid; Hydrogen Peroxide; Neoplasms; Nitrogen; Phototherapy; Porosity; Tumor Microenvironment | 2023 |
"All-in-One" Theranostic Agent with Seven Functions Based on Bi-Doped Metal Chalcogenide Nanoflowers.
Topics: Animals; Bismuth; Chalcogens; Combined Modality Therapy; Copper; Doxorubicin; Drug Carriers; Drug Liberation; HeLa Cells; Humans; Mice; Nanostructures; Neoplasms; Photoacoustic Techniques; Photochemotherapy; Singlet Oxygen; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2019 |
UCNP-Bi
Topics: Bismuth; Cell Line, Tumor; Cell Survival; Contrast Media; Endocytosis; Humans; Light; Metal Nanoparticles; Microscopy, Fluorescence; Neoplasms; Organoselenium Compounds; Phototherapy; Selenium Compounds; Tomography, X-Ray Computed | 2020 |
Biodegradable Bi
Topics: Bismuth; Cell Line, Tumor; Humans; Neoplasms; Organoselenium Compounds; Photoacoustic Techniques; Phototherapy; Powder Diffraction; Quantum Dots; Selenium Compounds; Spectrophotometry, Ultraviolet; Spectroscopy, Near-Infrared | 2020 |
BiO
Topics: Animals; Antineoplastic Agents; Bismuth; Catalase; Cell Line, Tumor; DNA; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Mice, Inbred BALB C; Nanostructures; Neoplasms; Oxygen; Radiation-Sensitizing Agents; Tumor Hypoxia; X-Rays; Xenograft Model Antitumor Assays | 2020 |
Spatiotemporally Synchronous Oxygen Self-Supply and Reactive Oxygen Species Production on Z-Scheme Heterostructures for Hypoxic Tumor Therapy.
Topics: Animals; Bismuth; Cell Line, Tumor; Mice; Nanotubes; Neoplasms; Oxygen; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Sulfides; Tumor Hypoxia | 2020 |
Accurate and Real-Time Temperature Monitoring during MR Imaging Guided PTT.
Topics: Animals; Bismuth; Gadolinium; Magnetic Resonance Imaging; Mice; Nanostructures; Neoplasms; Photothermal Therapy; Sodium Fluoride; Temperature; Thermography | 2020 |
Integration of Fe
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzidines; Bismuth; Catalysis; Cattle; Cell Line, Tumor; Contrast Media; Humans; Hydroxyl Radical; Indoles; Magnetic Resonance Imaging; Magnetite Nanoparticles; Neoplasms; Polymers; Serum Albumin, Bovine; Sulfides; Theranostic Nanomedicine; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2020 |
A continuous stimuli-responsive system for NIR-II fluorescence/photoacoustic imaging guided photothermal/gas synergistic therapy.
Topics: Allyl Compounds; Azides; Bismuth; Gases; Hydrogen Sulfide; Nanoparticles; Neoplasms; Optical Imaging; Oxidation-Reduction; Photoacoustic Techniques; Photochemotherapy; Silver Compounds; Sulfides; Theranostic Nanomedicine; Tumor Microenvironment | 2020 |
Multifunctional Bismuth Ferrite Nanocatalysts with Optical and Magnetic Functions for Ultrasound-Enhanced Tumor Theranostics.
Topics: Bismuth; Ferric Compounds; Humans; Hydrogen Peroxide; Neoplasms; Precision Medicine | 2020 |
Boosted photocatalytic activity induced NAMPT-Regulating therapy based on elemental bismuth-humic acids heterojunction for inhibiting tumor proliferation/migration/inflammation.
Topics: Acrylamides; Bismuth; Cell Proliferation; Cytokines; Humans; Humic Substances; Inflammation; Neoplasms; Piperidines | 2020 |
Suppressing the Radiation-Induced Corrosion of Bismuth Nanoparticles for Enhanced Synergistic Cancer Radiophototherapy.
Topics: Bismuth; Corrosion; Humans; Hydrogen Peroxide; Nanoparticles; Neoplasms; Tumor Microenvironment | 2020 |
Redox/photo dual-responsive, self-targeted, and photosensitizer-laden bismuth sulfide nanourchins for combination therapy in cancer.
Topics: Bismuth; Cell Line, Tumor; Humans; Hyperthermia, Induced; Indocyanine Green; Nanoparticles; Neoplasms; Oxidation-Reduction; Photosensitizing Agents; Phototherapy; Sulfides; Tissue Distribution | 2021 |
Cell membrane camouflaged bismuth nanoparticles for targeted photothermal therapy of homotypic tumors.
Topics: Animals; Bismuth; Cell Membrane; Mice; Nanoparticles; Neoplasms; Phototherapy; Photothermal Therapy | 2021 |
Hetero-Core-Shell BiNS-Fe@Fe as a Potential Theranostic Nanoplatform for Multimodal Imaging-Guided Simultaneous Photothermal-Photodynamic and Chemodynamic Treatment.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bismuth; Hep G2 Cells; Humans; Infrared Rays; Iron; Metal Nanoparticles; Mice; Multimodal Imaging; Neoplasms; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Reactive Oxygen Species; Theranostic Nanomedicine | 2021 |
Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy
Topics: Bismuth; Cell Line, Tumor; Chemoradiotherapy; Cisplatin; DNA Damage; Humans; Neoplasms; Nitrates; Prodrugs | 2021 |
Tuning the Kinetic Inertness of Bi
Topics: Bismuth; Chelating Agents; Coordination Complexes; Crown Ethers; Density Functional Theory; Humans; Kinetics; Ligands; Molecular Structure; Neoplasms; Radiopharmaceuticals | 2021 |
Albumin-Templated Bi
Topics: Animals; Antineoplastic Agents; Bismuth; Catalysis; Cattle; Cell Line, Tumor; Contrast Media; Female; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Peroxide; Manganese Compounds; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Oxides; Oxygen; Precision Medicine; Radiation-Sensitizing Agents; Selenium Compounds | 2021 |
Impact of the Spectral Composition of Kilovoltage X-rays on High-Z Nanoparticle-Assisted Dose Enhancement.
Topics: Bismuth; Copper; Dose-Response Relationship, Drug; Humans; Metal Nanoparticles; Monte Carlo Method; Neoplasms; Oxides; Radiation-Sensitizing Agents; Radiotherapy Dosage | 2021 |
Tumor Microenvironment Modulation Platform Based on Composite Biodegradable Bismuth-Manganese Radiosensitizer for Inhibiting Radioresistant Hypoxic Tumors.
Topics: Bismuth; Humans; Hypoxia; Manganese; Manganese Compounds; Neoplasms; Oxides; Tumor Microenvironment | 2021 |
Mitochondria-Targeting Enhanced Phototherapy by Intrinsic Characteristics Engineered "One-for-All" Nanoparticles.
Topics: Animals; Antineoplastic Agents; Bismuth; Female; HeLa Cells; Humans; Iron; Mice, Inbred BALB C; Mitochondria; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Photothermal Therapy; Reactive Oxygen Species; Sulfides | 2021 |
A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
Topics: Actinium; Alpha Particles; Bismuth; DNA Repair; Humans; Neoplasms; Organ Sparing Treatments; Radioisotopes; Radiopharmaceuticals | 2017 |
A simple stripping voltammetric method for the determination of a new anticancer prodrug in serum.
Topics: Adsorption; Biosensing Techniques; Bismuth; Electrochemistry; Electrodes; Humans; Hydrogen-Ion Concentration; Limit of Detection; Neoplasms; Prodrugs | 2017 |
Ultrasmall Semimetal Nanoparticles of Bismuth for Dual-Modal Computed Tomography/Photoacoustic Imaging and Synergistic Thermoradiotherapy.
Topics: Animals; Antineoplastic Agents; Bismuth; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Contrast Media; Drug Carriers; Drug Liberation; Humans; Mice, Inbred BALB C; Multimodal Imaging; Nanoparticles; Neoplasms; Particle Size; Peptides, Cyclic; Photoacoustic Techniques; Phototherapy; Radiotherapy; Surface Properties; Tomography, X-Ray Computed | 2017 |
Biocompatible PEGylated bismuth nanocrystals: "All-in-one" theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors.
Topics: Animals; Bismuth; Contrast Media; Female; HeLa Cells; Humans; Hyperthermia, Induced; Mice, Inbred BALB C; Multimodal Imaging; Nanoparticles; Neoplasms; Photoacoustic Techniques; Phototherapy; Polyethylene Glycols; Theranostic Nanomedicine; Thermography; Tomography, X-Ray Computed | 2017 |
Poly(Vinylpyrollidone)- and Selenocysteine-Modified Bi
Topics: Bismuth; Humans; Nanoparticles; Neoplasms; Organoselenium Compounds; Polyvinyls; Pyrrolidinones; Radiation-Sensitizing Agents; Selenium Compounds; Selenocysteine; Theranostic Nanomedicine | 2017 |
Hyaluronic acid-functionalized bismuth oxide nanoparticles for computed tomography imaging-guided radiotherapy of tumor.
Topics: Animals; Bismuth; Cell Line, Tumor; Contrast Media; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Mice, Inbred ICR; Nanoparticles; Neoplasms; Radiation-Sensitizing Agents; Radiotherapy, Image-Guided; Theranostic Nanomedicine; Tissue Distribution; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2017 |
Deep-Level Defect Enhanced Photothermal Performance of Bismuth Sulfide-Gold Heterojunction Nanorods for Photothermal Therapy of Cancer Guided by Computed Tomography Imaging.
Topics: Animals; Bismuth; Cell Line, Tumor; Combined Modality Therapy; Gold; Heterografts; HSP70 Heat-Shock Proteins; Humans; Hyperthermia, Induced; Infrared Rays; Mice; Mice, Inbred BALB C; Microscopy, Electron; Nanotubes; Neoplasms; Photoelectron Spectroscopy; Phototherapy; Spectrophotometry, Ultraviolet; Sulfides; Theranostic Nanomedicine; Tomography, X-Ray Computed | 2018 |
Renal-Clearable Hollow Bismuth Subcarbonate Nanotubes for Tumor Targeted Computed Tomography Imaging and Chemoradiotherapy.
Topics: Animals; Antibiotics, Antineoplastic; Bismuth; Carbonates; Cell Line, Tumor; Chemoradiotherapy; Contrast Media; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Kidney; Mice; Mice, Inbred BALB C; Mice, Nude; Nanotubes; Neoplasms; Tomography, X-Ray Computed | 2018 |
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes | 2018 |
Bi
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Bismuth; Cell Line, Tumor; Cell Survival; Chromones; Down-Regulation; Hemolysis; HSP70 Heat-Shock Proteins; Humans; Hyperthermia, Induced; Infrared Rays; Mice; Mice, Nude; Morpholines; Nanoparticles; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Phototherapy; Polysorbates; Sulfides | 2018 |
The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.
Topics: Actinium; Alpha Particles; Animals; Bismuth; Humans; Neoplasms; Radiochemistry; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals | 2018 |
PEGylated mesoporous Bi
Topics: Animals; Antibiotics, Antineoplastic; Bismuth; Cell Line, Tumor; Chlorophyllides; Delayed-Action Preparations; Doxorubicin; Hyperthermia, Induced; Mice; Nanoparticles; Neoplasms; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Porosity; Porphyrins; Sulfides; Theranostic Nanomedicine; Tomography, X-Ray Computed | 2019 |
Recoverable Bismuth-Based Microrobots: Capture, Transport, and On-Demand Release of Heavy Metals and an Anticancer Drug in Confined Spaces.
Topics: Antineoplastic Agents; Bismuth; Chromium; Confined Spaces; Doxorubicin; Drug Liberation; Humans; Metals, Heavy; Nanotechnology; Neoplasms; Platinum | 2019 |
Gram-scale fabrication of Bi@C nanoparticles through one-step hydrothermal method for dual-model imaging-guided NIR-II photothermal therapy.
Topics: Animals; Bismuth; Carbon; Cell Survival; HeLa Cells; Humans; Hypothermia, Induced; Infrared Rays; Mice; Nanoparticles; Neoplasms; Phototherapy; Tomography, X-Ray Computed; Transplantation, Heterologous | 2019 |
Synthesis of Bi
Topics: Animals; Bismuth; Cell Line, Tumor; Cell Survival; Infrared Rays; Iohexol; Mice; Nanostructures; Neoplasms; Oxygen; Photochemotherapy; Phototherapy; Singlet Oxygen; Temperature; Tissue Distribution; Tomography, X-Ray Computed; Tungsten Compounds | 2019 |
Alpha-particle emitting 213Bi-anti-EGFR immunoconjugates eradicate tumor cells independent of oxygenation.
Topics: Alpha Particles; Antibodies, Monoclonal, Humanized; Bismuth; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Cell Survival; ErbB Receptors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoconjugates; Neoplasms; Oxygen; Particle Accelerators; Photons; Radioisotopes | 2013 |
A Facile One-Pot Synthesis of a Two-Dimensional MoS2 /Bi2S3 Composite Theranostic Nanosystem for Multi-Modality Tumor Imaging and Therapy.
Topics: Animals; Bismuth; Cell Line, Tumor; Contrast Media; Disulfides; Humans; Infrared Rays; Mice; Mice, Nude; Molybdenum; Nanostructures; Neoplasms; Phototherapy; Polyethylene Glycols; Sulfides; Survival Rate; Theranostic Nanomedicine; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Layered bismuth oxyhalide nanomaterials for highly efficient tumor photodynamic therapy.
Topics: Bismuth; Humans; MCF-7 Cells; Nanostructures; Neoplasms; Photochemotherapy; Photosensitizing Agents | 2016 |
Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines.
Topics: Animals; Antimony; Antineoplastic Agents; Apoptosis; Bismuth; Cell Line; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Humans; Mice; Models, Molecular; Neoplasms | 2016 |
Perfluorocarbon-Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near-Infrared Light to Enhance the Radiotherapy of Cancer.
Topics: Animals; Bismuth; Cell Line, Tumor; Cell Survival; DNA Damage; Fluorocarbons; Infrared Rays; Metal Nanoparticles; Mice; Microscopy, Electron, Transmission; Neoplasms; Organoselenium Compounds; Oxygen; Polyethylene Glycols; Selenium Compounds; Transplantation, Homologous | 2016 |
Rapid Degradation and High Renal Clearance of Cu3BiS3 Nanodots for Efficient Cancer Diagnosis and Photothermal Therapy in Vivo.
Topics: Animals; Antineoplastic Agents; Bismuth; Cell Survival; Copper; Humans; Kidney; MCF-7 Cells; Mice; Nanoparticles; Neoplasms; Particle Size; Photoacoustic Techniques; Phototherapy; Renal Reabsorption; Sulfides; Theranostic Nanomedicine; Tissue Distribution; Tomography, X-Ray Computed | 2016 |
Bismuth(III) complexes with 2-acetylpyridine- and 2-benzoylpyridine-derived hydrazones: Antimicrobial and cytotoxic activities and effects on the clonogenic survival of human solid tumor cells.
Topics: Animals; Anti-Infective Agents; Bacteria; Bismuth; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Colony-Forming Units Assay; Coordination Complexes; Humans; Hydrazones; Inhibitory Concentration 50; Neoplasms; Pyridines; Structure-Activity Relationship; Vero Cells | 2016 |
A new PET scanner with semiconductor detectors enables better identification of intratumoral inhomogeneity.
Topics: Adult; Aged; Bismuth; Cadmium Compounds; Carcinoma, Squamous Cell; Female; Germanium; Glucose; Humans; Male; Nasopharyngeal Neoplasms; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Semiconductors; Tellurium; Time Factors | 2009 |
Spectral performance of a composite single-crystal filtered thermal neutron beam for BNCT research at the University of Missouri.
Topics: Animals; Bismuth; Boron Neutron Capture Therapy; Crystallization; Equipment Design; Fast Neutrons; Humans; Missouri; Neoplasms; Nuclear Reactors; Silicon | 2009 |
Interim notes on the therapeutics of bismuth, antimony, zinc, iron, and copper arsanilate in the treatment of malignant disease, syphilis, yaws, leprosy, tuberculosis, whooping cough and some minor complaints in the African.
Topics: Antimony; Arsenic; Bismuth; Black People; Copper; Humans; Iron; Leprosy; Metals; Neoplasms; Syphilis; Therapeutics; Tuberculosis; Whooping Cough; Yaws; Zinc | 1946 |
Warty erythrokeratoderma with bronchial dilation transformed by bismuth treatment.
Topics: Antacids; Bismuth; Bronchi; Dilatation; Humans; Neoplasms | 1947 |
Porphyrin complexes of the period 6 main group and late transition metals.
Topics: Antineoplastic Agents; Bismuth; Catalysis; Coordination Complexes; Gold; Humans; Lead; Mercury; Metals, Heavy; Neoplasms; Porphyrins; Thallium; Transition Elements | 2011 |
Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates.
Topics: Antibodies, Monoclonal, Humanized; Bismuth; Drug Evaluation, Preclinical; Drug Stability; Glycine; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Isotope Labeling; Kinetics; Neoplasms; Trastuzumab | 2011 |
Roles of nucleation, denucleation, coarsening, and aggregation kinetics in nanoparticle preparations and neurological disease.
Topics: Aging; Animals; Biophysical Phenomena; Bismuth; Humans; Kinetics; Macromolecular Substances; Mathematical Concepts; Metal Nanoparticles; Models, Molecular; Models, Neurological; Multiprotein Complexes; Nanoparticles; Neoplasms; Nerve Tissue Proteins; Nervous System Diseases; Particle Size; Protein Multimerization; Thermodynamics | 2012 |
Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion protein.
Topics: Alpha Particles; Bismuth; Cadherins; Cell Survival; Exons; Gene Deletion; Humans; Neoplasms; Radioimmunotherapy; Terbium | 2003 |
Bismuth-206, a pure gamma-emitter for therapy.
Topics: Antacids; Bismuth; Gamma Rays; Humans; Neoplasms; Radioactivity; Radioisotopes | 1956 |
[Animal experiments and clinical examinations with radio-bismuth for the localization diagnosis of tumors].
Topics: Animal Experimentation; Animals; Bismuth; Humans; Neoplasms; Radioactivity; Radioisotopes | 1957 |
[Experimental & clinical research on radioactive bismuth; problem of diagnostic localization of tumors, preliminary note].
Topics: Antacids; Biomedical Research; Bismuth; Neoplasms; Radioactivity; Radioisotopes | 1957 |
[Research on behavior of heavy elements in animals with experimental neoplasms. I. Anorganic and organic compounds of bismuth 206 in Yoshida and Ehrlich ascites tumors].
Topics: Animals; Bismuth; Carcinoma, Ehrlich Tumor; Neoplasms; Neoplasms, Experimental; Radioisotopes; Research | 1957 |
[Research on the behavior of heavy elements in animals with experimental tumors. III. Accumulation of organic and inorganic bismuth 206 compounds in Yoshida-ascitessarcoma and benzpyrin tumors and the role of the reticuloendothelial system].
Topics: Animals; Bismuth; Mononuclear Phagocyte System; Neoplasms; Neoplasms, Experimental; Radioisotopes; Research | 1957 |
[Another radio-isotope for diagnostic location of brain diseases; first note].
Topics: Bismuth; Brain; Brain Diseases; Brain Neoplasms; Humans; Isotopes; Neoplasms; Radioisotopes | 1957 |
[Treatment of lymphatic leukemia & other malignant reticuloses with radiobismuth].
Topics: Bismuth; Humans; Leukemia; Leukemia, Lymphoid; Lymphoid Tissue; Neoplasms; Peptide Nucleic Acids; Radioisotopes | 1958 |
Therapeutic use of radioactive bismuth-isotopes in malignancies.
Topics: Bismuth; Neoplasms; Radioactivity; Radioisotopes | 1961 |
[The theoretical and experimental bases for therapy with radioactive bismuth, Bi-206].
Topics: Antacids; Bismuth; Humans; Neoplasms; Radioactivity; Radioisotopes | 1961 |
[ON A CASE OF SYPHILITIC PSEUDI-TUMOR OF THE STOMACH].
Topics: Antacids; Bismuth; Diagnosis, Differential; Hodgkin Disease; Humans; Neoplasms; Penicillins; Radiography; Salicylates; Stomach; Stomach Neoplasms; Syphilis; Syphilis Serodiagnosis | 1963 |
[INVESTIGATIONS ON THE DISTRIBUTION OF RADIOISOTOPES USED FOR BRAIN TUMOR DIAGNOSIS IN THE BLOOD CIRCULATION, IN EXPERIMENTAL TUMORS AND HUMAN BRAIN TUMORS].
Topics: Animals; Arsenic; Bismuth; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Copper; Edetic Acid; Humans; Iodine Isotopes; Mercury; Neoplasms; Neoplasms, Experimental; Radioisotopes; Research; Sarcoma; Sarcoma, Yoshida | 1963 |
RADIOACTIVE BISMUTH PHOSPHATE FOR THE TREATMENT OF CRANIOPHARYNGIOMA.
Topics: Adolescent; Bismuth; Child; Craniopharyngioma; Cysts; Electroencephalography; Humans; Neoplasms; Phosphates; Phosphorus Isotopes; Pituitary Neoplasms; Punctures; Radioactivity; Radiography; Radioisotope Teletherapy; Radiotherapy, High-Energy | 1964 |
CONTOUR BRAIN SCANNING WITH IODINE AND MERCURY COMPOUNDS FOR DETECTION OF INTRACRANIAL TUMORS.
Topics: Arsenicals; Bismuth; Brain; Brain Neoplasms; Chlormerodrin; Diuretics; Glioma; Hemangiosarcoma; Iodine; Meningeal Neoplasms; Meningioma; Mercury Compounds; Neoplasms; Organomercury Compounds; Radioisotopes; Radionuclide Imaging; Serum Albumin; Serum Albumin, Radio-Iodinated; Statistics as Topic | 1964 |
The amount of bismuth and its significance in tumor.
Topics: Antacids; Antidiarrheals; Bismuth; Neoplasms | 1951 |
Targeted alpha therapy for cancer.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Apoptosis; Bismuth; Cell Line, Tumor; Chelating Agents; Clinical Trials as Topic; Female; Flow Cytometry; Humans; Kinetics; Male; Melanoma; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Prostatic Neoplasms; Radioisotopes; Radiotherapy; Sensitivity and Specificity; Skin Neoplasms; Time Factors | 2004 |
A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
Topics: Actinium; Alpha Particles; Apoptosis; Beta Particles; Bismuth; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Enzyme-Linked Immunosorbent Assay; Humans; Ligands; Lutetium; Mitosis; Models, Statistical; Neoplasms; Octreotide; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin | 2005 |
Addendum to: Basic immunology of antibody targeted radiotherapy: in regard to Wong (Int J Radiat Oncol Biol Phys 2006;66: S8-S14).
Topics: Actinium; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Bismuth; Chondroitin Sulfate Proteoglycans; Humans; Membrane Proteins; Neoplasms; Radioimmunotherapy; Radioisotopes | 2007 |
Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors.
Topics: Amino Acid Sequence; Animals; Bacteriophage M13; Binding, Competitive; Bismuth; Chelating Agents; Consensus Sequence; Electrophoresis, Polyacrylamide Gel; Female; Hydroxylamines; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, SCID; Molecular Sequence Data; Neoplasms; Peptide Library; Peptides; Radiography; Radioimmunotherapy; Radioisotopes; Tissue Distribution | 2000 |
[Therapeutic news of 1975].
Topics: Bismuth; Cardiovascular Diseases; Diazepam; Drug Therapy; Endocrine System Diseases; Gastrointestinal Diseases; Glafenine; Hepatitis; Humans; Hydroxyquinolines; Hypersensitivity; Infections; Kidney Diseases; Metabolic Diseases; Neoplasms; Nervous System Diseases; Practolol; Respiratory Tract Diseases; Rheumatic Diseases | 1976 |
[The alley B.P.F. (bismuth, lead, tin and cadmium) in irradiation using conforming fields].
Topics: Alloys; Bismuth; Cadmium; Humans; Lead; Neoplasms; Radiotherapy; Tin | 1975 |
Scientists closer to using alpha-particle-emitting isotopes as cancer treatment.
Topics: Alpha Particles; Antibodies, Monoclonal; Bismuth; Humans; Neoplasms; Radioisotopes | 1990 |
[A method of cisplatin administration with the aid of high-dose bismuth subnitrate, and their pharmacokinetics].
Topics: Administration, Oral; Antacids; Bismuth; Cisplatin; Humans; Injections, Intravenous; Metallothionein; Neoplasms | 1989 |
Radiation in dwellings and cancer in children.
Topics: Adolescent; Background Radiation; Bismuth; Case-Control Studies; Child; Child, Preschool; Construction Materials; Female; Heating; Housing; Humans; Infant; Lead; Male; Neoplasms; Neoplasms, Radiation-Induced; Polonium; Radon Daughters; Sweden | 1987 |
Intraarterial distribution of colloidal bismuth compounds injected in man.
Topics: Adolescent; Aged; Bismuth; Bone Neoplasms; Female; Femur; Humans; Iliac Artery; Injections, Intra-Arterial; Leg; Liver; Male; Middle Aged; Mouth Neoplasms; Neoplasms; Osteosarcoma; Radioisotopes; Radionuclide Imaging; Sarcoma, Ewing; Spleen; Tibia; Urinary Bladder Neoplasms | 1972 |
[Contribution on lues visceralis].
Topics: Adult; Bismuth; Bone Diseases; Diagnosis, Differential; Humans; Iodine; Kidney Diseases; Lung Diseases; Male; Mercury; Middle Aged; Neoplasms; Penicillins; Psittacosis; Stomach Diseases; Syphilis; Syphilis Serodiagnosis; Syphilis, Cardiovascular | 1966 |